Can-Fite BioPharma Ltd. Stock Issued During Period, Value, Other
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
| Period end | Stock Issued During Period, Value, Other 3 month | Stock Issued During Period, Value, Other 12 month |
|---|---|---|
| 2021-12-31 | $68.00K 20-F · filed 2023-03-30 | |
| 2019-12-31 | $11.67M 6-K · filed 2020-06-01 | |
| 2018-12-31 | $4.39M 6-K · filed 2020-06-01 | |
| 2017-12-31 | $2.81M 6-K · filed 2020-06-01 |